DB Power and LPA announce strategic partnership to globally expand solutions for issuers of structured retail products

Real Time Search
CES A80 :
CES HKMI :
CES 120 :
Total Turn.

02157 LEPU BIO-B

Closed Add to Porfolio
Index Constituent : HS Composite Index, HS Comp. M & S Index, HS Comp.SmallCap Ind, Stock Connect HK Ind, Stock Connect HK MS, Stock Connect HK S I
Major Shareholders Pu Zhongjie (36.50%)
Hu Chaohong (6.72%)		 Sector Health Care & Biotechnology
Web Site http://www.lepubiopharma.com Tel (852) 3150-6788
Email lepu.hk@pordahavas.com Fax (852) 3150-6728
Related Equities N/A
Principal Activities Principally focus on the discovery, development and commercialization in global of drugs for cancer targeted therapy and immunotherapy.

Consolidated List of Substantial Shareholders

Name Number of Shares Interested % of Issued Share Capital (%) Date of Last Notice Filed (Y/M/D)
Last Update :
Note : (L) - Long Position (S) - Short Position (P) - Lending Pool

Complete List of Directors

Director's Name Number of Shares Interested % of issued share capital (%) Date of Last Notice Filed (Y/M/D)
Last Update :
Note : (L) - Long Position (S) - Short Position (P) - Lending Pool
Back to Top